MAPT and Alzheimer disease: In post-mortem human brains afflicted with AD, PLA was used to visualize and quantify aggregates of ubiquitin-modified, hyperphosphorylated tau, thus providing in situ demonstration of the specific PTMs associated with pathological tau aggregates [106].